InsidersTradesSigma
Total declarations
Company
▲ Purchases (5 ops.)
▼ Sales (0 ops.)
Discover the complete record of transactions filed by He Wei-Wu, Chairman & CEO. Officer active across 1 companies, notably CASI Pharmaceuticals, Inc.. Cumulatively, 5 filings have been published. Total volume traded: €1.1m. The latest transaction was filed on 13 June 2022 (Acquisition). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations5 total
€102,82436,058 shares@ €2.85163.55% mcap9.2% of flow
Common Stock
SEC:0001104659-22-072392:0·
Ideal exit: 10 Mar 2023 (T+270)
€174,893200,000 shares@ €0.874534.6% of flow
Common Stock
SEC:0001104659-21-141867·
Ideal exit: 14 Aug 2022 (T+270)
€174,893200,000 shares@ €0.87456.04% mcap15.7% of flow
Common Stock
SEC:0001104659-21-141867:0·
Ideal exit: 14 Aug 2022 (T+270)
€330,676300,000 shares@ €1.102365.4% of flow
Common Stock
SEC:0001104659-21-108182·
Ideal exit: 15 May 2022 (T+270)
€330,676300,000 shares@ €1.102311.41% mcap29.7% of flow
Common Stock
SEC:0001104659-21-108182:0·
Ideal exit: 15 May 2022 (T+270)
5 of 5 declarations
About He Wei-Wu
He Wei-Wu is the Chairman and CEO of CASI Pharmaceuticals, Inc., a company focused on developing innovative treatments for serious diseases. Under his leadership, the company is committed to providing high-quality therapeutic solutions and improving patients' lives. He Wei-Wu plays a key role in the company's strategy and vision, overseeing operations and guiding the team towards achieving growth and innovation objectives.
